385 related articles for article (PubMed ID: 27652601)
1. Pregnancy and Antiphospholipid Syndrome.
Schreiber K; Hunt BJ
Semin Thromb Hemost; 2016 Oct; 42(7):780-788. PubMed ID: 27652601
[TBL] [Abstract][Full Text] [Related]
2. Current insights in obstetric antiphospholipid syndrome.
Schreiber K; Radin M; Sciascia S
Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
[TBL] [Abstract][Full Text] [Related]
3. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?
de Jesús GR; Rodrigues G; de Jesús NR; Levy RA
Curr Rheumatol Rep; 2014 Feb; 16(2):403. PubMed ID: 24390757
[TBL] [Abstract][Full Text] [Related]
5. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.
Bertolaccini ML; Contento G; Lennen R; Sanna G; Blower PJ; Ma MT; Sunassee K; Girardi G
J Autoimmun; 2016 Dec; 75():30-38. PubMed ID: 27160365
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
Sciascia S; Branch DW; Levy RA; Middeldorp S; Pavord S; Roccatello D; Ruiz-Irastorza G; Tincani A; Khamashta M; Schreiber K; Hunt BJ
Thromb Haemost; 2016 Jan; 115(2):285-90. PubMed ID: 26421409
[TBL] [Abstract][Full Text] [Related]
7. Anticardiolipin Positivity Is Highly Associated With Intrauterine Growth Restriction in Women With Antiphospholipid Syndrome.
Xi F; Cai Y; Lv M; Jiang Y; Zhou F; Chen Y; Jiang L; Luo Q
Clin Appl Thromb Hemost; 2020; 26():1076029620974455. PubMed ID: 33296221
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
Khizroeva J; Bitsadze V; Tincani A; Makatsariya A; Arslanbekova M; Babaeva N; Tsibizova V; Shkoda A; Makatsariya N; Tretyakova M; Solopova A; Gadaeva Z; Vorobev A; Khamani I; Aslanova Z; Nakaidze I; Mischenko A; Grigoreva K; Kunesko N; Egorova E; Mashkova T
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6157-6164. PubMed ID: 34044735
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
[TBL] [Abstract][Full Text] [Related]
10. Managing antiphospholipid syndrome in pregnancy.
Schreiber K; Hunt BJ
Thromb Res; 2019 Sep; 181 Suppl 1():S41-S46. PubMed ID: 31477227
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine.
Latino JO; Udry S; Aranda F; Wingeyer SP; Romero DSF; Belizna C; Larrañaga G
Lupus; 2020 Nov; 29(13):1736-1742. PubMed ID: 32838621
[TBL] [Abstract][Full Text] [Related]
12. Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review.
Hooper A; Bacal V; Bedaiwy MA
Am J Reprod Immunol; 2023 Sep; 90(3):e13761. PubMed ID: 37641373
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
[TBL] [Abstract][Full Text] [Related]
14. Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome.
Liu J; Zhang L; Tian Y; Wan S; Hu M; Song S; Zhang M; Zhou Q; Xia Y; Wang X
J Cell Mol Med; 2022 Aug; 26(15):4357-4370. PubMed ID: 35770338
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
[TBL] [Abstract][Full Text] [Related]
16. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies.
Sciascia S; Hunt BJ; Talavera-Garcia E; Lliso G; Khamashta MA; Cuadrado MJ
Am J Obstet Gynecol; 2016 Feb; 214(2):273.e1-273.e8. PubMed ID: 26429521
[TBL] [Abstract][Full Text] [Related]
17. [Pregnancy and antiphospholipid syndrome].
Costedoat-Chalumeau N; Guettrot-Imbert G; Leguern V; Leroux G; Le Thi Huong D; Wechsler B; Morel N; Vauthier-Brouzes D; Dommergues M; Cornet A; Aumaître O; Pourrat O; Piette JC; Nizard J
Rev Med Interne; 2012 Apr; 33(4):209-16. PubMed ID: 22341691
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
[TBL] [Abstract][Full Text] [Related]
19. Effect of hydroxychloroquine on antiphospholipid antibodies-inhibited endometrial angiogenesis.
Dong Y; Lu Y; Xia Y; Wang X
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7084-7092. PubMed ID: 34182874
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antiphospholipid antibody levels.
Mekinian A; Loire-Berson P; Nicaise-Roland P; Lachassinne E; Stirnemann J; Boffa MC; Chollet-Martin S; Carbillon L; Fain O
J Reprod Immunol; 2012 Jun; 94(2):222-6. PubMed ID: 22386067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
